Although experimental studies suggest potential pancreatic harm from GLP-1 RAs, robust clinical evidence demonstrates that these drugs do not increase the incidence of pancreatitis or pancreatic cancer in diverse human populations
For planned pregnancies, semaglutide should be discontinued at least 2 months before conception due to its long half-life
NDA initiationGlobalNeoadjuvant primary uveal melanomaPhase 2/3OngoingUS IDE397IDE397 / MAT2A / Small Molecule / OncologyMTAP-deleted solid tumorsPhase 1OngoingUS IDE849IDE849 / DLL3 / ADC / OncologyDLL3-expressing solid tumors (SCLC, NEC)Phase 1OngoingUS IDE161IDE161 / PARG / Small Molecule / OncologyHRD solid tumorsPhase 1RecruitingUS IDE034IDE034 / PTK7/B7H3 / Bispecific ADC / OncologyB7H3/PTK7 solid tumors (NSCLC, CRC, breast, ovarian)Phase 1OngoingUS IDE892IDE892 / PRMT5 / Small Molecule / OncologyMTAP-deleted solid tumorsPhase 1OngoingUS IDE574IDE574 / KAT6/7 / Small Molecule / OncologySolid tumors (breast, prostate, CRC, lung)Phase 1OngoingUS IDE275IDE275 / Werner Helicase (WRN) / Small Molecule / OncologyMSI-high solid tumorsPhase 1OngoingUS IDE705IDE705 / Pol Theta (POLQ) / Small Molecule / OncologyHRD solid tumorsPhase 1OngoingUS 9assets BrensocatibBRINSUPRI / DPP1 / Small Molecule / Respiratory / ImmunologyNon-Cystic Fibrosis Bronchiectasis (NCFB)MarketedActiveUSEUHidradenitis SuppurativaPhase 2ActiveGlobal Amikacin Liposome Inhalation SuspensionARIKAYCE / Bacterial 30S ribosomal subunit / Liposomal Inhalation Suspension / Respiratory / Infectious DiseaseRefractory Mycobacterium avium complex (MAC) Lung DiseaseMarketedActiveUSEUJPMAC Lung Disease (Label Expansion)Phase 3ActiveGlobal Treprostinil Palmitil Inhalation PowderTPIP / Prostacyclin receptor / Inhalation Powder / Respiratory / PulmonaryPulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD)Phase 3ActiveGlobalPulmonary Arterial Hypertension (PAH)Phase 3ActiveGlobalProgressive Pulmonary Fibrosis (PPF)Phase 3 PlannedActiveGlobal INS1148INS1148 / Stem Cell Factor SCF248 / Monoclonal Antibody / Respiratory / ImmunologyInterstitial Lung Disease (ILD)Phase 2ActiveGlobalModerate-to-severe asthmaPhase 2ActiveGlobal INS1033INS1033 / Unknown / Unknown / Immunology & InflammationInflammatory diseasesPreclinicalActiveGlobal Intrathecal gene therapy for DMDDystrophin / Gene Therapy / Neurology / Rare DiseaseDuchenne Muscular Dystrophy (DMD)Phase 1ActiveGlobal INS1202INS1202 / Unknown / Unknown / Neurology / Rare DiseaseAmyotrophic Lateral Sclerosis (ALS)Phase 1ActiveGlobal Stargardt Disease Gene TherapyUnknown / Gene Therapy / Ophthalmology / Rare DiseaseStargardt DiseasePreclinicalActiveGlobal Next-Gen DPP1 InhibitorsDPP1 / Small Molecule / Immunology & InflammationUndisclosedPreclinicalActiveGlobal 9assets ZanidatamabHER2 / Bispecific Antibody / OncologyBiliary Tract Cancers (BTC)Gastroesophageal Adenocarcinoma (GEA)Colorectal Cancer (CRC) LurbinectedinZepzelca / DNA alkylating / Small Molecule / OncologySmall Cell Lung Cancer (SCLC)Ewing Sarcoma DordaviproneModeyso / ClpP agonist / DRD2 antagonist / Small Molecule / OncologyH3 K27M-mutant diffuse glioma Daunorubicin and cytarabineJZP351 / Vyxeos / Vyxeos Liposomal / Topoisomerase inhibitor / nucleoside metabolic inhibitor / Liposomal Combination / OncologyMyelodysplastic Syndromes (MDS)Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) JZP898JZP898 / IFN2b cytokine pro-drug / Biologic / OncologySolid Tumors JZP3507JZP3507 / ClpP agonist / DRD2 antagonist / Small Molecule / OncologyOncology JZP815JZP815 / pan-RAF / Small Molecule / OncologySolid TumorsHematologic Malignancies CannabidiolEpidyolex / Cannabinoid Receptors / Small Molecule / NeuroscienceLennox-Gastaut Syndrome (LGS)Dravet Syndrome (DS)Tuberous Sclerosis Complex (TSC) JZP441JZP441 / Orexin-2 receptor agonist / Small Molecule / NeuroscienceNarcolepsy Type 1Idiopathic Hypersomnia 9assets pembrolizumabMK-3475 / Keytruda belzutifanMK-6482 / Welireg sotaterceptMK-7962 sacituzumab tirumotecanMK-2870 efinopegdutideMK-6024 gocatamigMK-6070 9assets 9assets Isaralgagene civaparvovecST-920 / alpha-galactosidase A (GLA) / Gene Therapy (AAV) / Metabolic DiseasesFabry DiseaseBLA/FilingActiveUS Giroctogene fitelparvovecSB-525 / Factor VIII / Gene Therapy (AAV) / HematologyHemophilia APhase 3ActiveUS ST-503ST-503 / Nav1.7 (SCN9A) / Gene Therapy (Zinc Finger Repressor, AAV9) / NeurologySmall Fiber Neuropathy (Chronic Neuropathic Pain)Phase 1/2ActiveUS ST-506ST-506 / Prion protein (PRNP) / Gene Therapy (Zinc Finger Repressor, STAC-BBB AAV) / NeurologyPrion DiseasePreclinicalActiveUS TX200TX200 / HLA-A2 / Cell Therapy (Autologous CAR-Treg) / TransplantationPrevention of Immune-Mediated Rejection in HLA-A2 Mismatched Kidney TransplantationPhase 1/2ActiveUSEurope IL23R CAR-TregIL23R / Cell Therapy (CAR-Treg) / AutoimmunityInflammatory Bowel Disease (Crohn's Disease)PreclinicalActiveGlobal Genentech Tau ProgramTau / Gene Therapy (Zinc Finger Epigenetic Regulator) / NeurologyTauopathies / Alzheimer's DiseasePreclinicalActiveGlobal Takeda Huntington's ProgramHTT / Gene Therapy (Zinc Finger Epigenetic Regulator) / NeurologyHuntington's DiseasePreclinicalActiveGlobal Alexion C9ORF72 ProgramC9ORF72 / Gene Therapy (Zinc Finger Transcription Factor) / NeurologyAmyotrophic Lateral Sclerosis (ALS)PreclinicalActiveGlobalFrontotemporal Lobar Degeneration (FTLD)PreclinicalActiveGlobal 9assets Olanzapine LAITEV-'749 DuvakitugAnti-TL1A DARI (ICS/SABA)TEV-'248 EmrusolminTEV-'286 Anti-IL-15TEV-'408 Anti-PD1-IL2TEV-'278 Sery433TEV-'2871 9assets SuzetrigineVX-548 / Journavx / NaV1.8 / Small Molecule / PainModerate-to-Severe Acute PainPainful Diabetic Peripheral Neuropathy VX-993VX-993 / NaV1.8 / Small Molecule / PainPainful Diabetic Peripheral NeuropathyModerate-to-Severe Acute Pain Vanzacaftor/tezacaftor/deutivacaftorCFTR / Small Molecule / Cystic FibrosisCystic Fibrosis VX-522VX-522 / CFTR / mRNA / Cystic FibrosisCystic Fibrosis (non-responsive to modulators) InaxaplinVX-147 / APOL1 / Small Molecule / Kidney DiseaseAPOL1-mediated Kidney Disease (AMKD) VX-407VX-407 / PC1 / Small Molecule / Kidney DiseaseAutosomal Dominant Polycystic Kidney Disease (ADPKD) VX-880VX-880 / Islet Cell / Cell Therapy / Type 1 DiabetesType 1 Diabetes VX-264VX-264 / Islet Cell / Cell Therapy / Type 1 DiabetesType 1 Diabetes PovetaciceptALPN-303 / BAFF/APRIL / Biologic / Autoimmune / Kidney DiseaseIgA Nephropathy 9assets XmAb819XmAb819 / ENPP3 x CD3 / Bispecific Antibody / OncologyClear Cell Renal Cell Carcinoma (ccRCC)Phase 1ActiveGlobalColorectal Cancer (CRC)Phase 1ActiveGlobalNon-Small Cell Lung Cancer (NSCLC)Phase 1ActiveGlobal XmAb541XmAb541 / CLDN6 x CD3 / Bispecific Antibody / OncologyOvarian CancerPhase 1ActiveGlobalGerm Cell Tumors (GCT)Phase 1ActiveGlobalSolid TumorsPhase 1ActiveGlobal XmAb808XmAb808 / B7-H3 x CD28 / Bispecific Antibody / OncologyProstate Cancer / Solid TumorsPhase 1ActiveGlobal XmAb942XmAb942 / TL1A / Monoclonal Antibody / ImmunologyUlcerative Colitis (UC)Phase 2ActiveGlobalInflammatory Bowel Disease (IBD)Phase 2ActiveGlobal XmAb412XmAb412 / TL1A x IL23p19 / Bispecific Antibody / ImmunologyInflammatory Bowel Disease (IBD)Phase 1ActiveGlobal PlamotamabCD20 x CD3 / Bispecific Antibody / ImmunologyRheumatoid ArthritisPhase 1ActiveGlobal XmAb657XmAb657 / CD19 x CD3 / Bispecific Antibody / ImmunologyIdiopathic Inflammatory MyositisPhase 1ActiveGlobal ObexelimabCD19 x FcRIIb / Monoclonal Antibody / ImmunologyAutoimmune DiseasesPhase 3ActiveGlobal TobevibartHepatitis B Virus / Monoclonal Antibody / Infectious DiseaseChronic Hepatitis B / Hepatitis DPhase 3ActiveGlobal 8assets Insulin AspartAMP-004 / interchangeable biosimilar insulin / Diabetes Recombinant Human InsulinAMP-005 / interchangeable biosimilar insulin / Diabetes AMP-028AMP-028 / biosimilar Intranasal epinephrineAMP-019 / adrenergic receptors / intranasal small molecule / Allergy/ImmunologyAnaphylaxis/allergic reactionsdevelopment AMP-105AMP-105 / peptide / OncologyPoorly treated cancersdevelopmentUnited StatesCanada AMP-107AMP-107 / VEGFR / topical eye-drop peptide / OphthalmologyWet age-related macular degenerationdevelopmentUnited StatesCanada AMP-109AMP-109 / peptide-docetaxel conjugate / OncologyCancerdevelopmentUnited StatesCanada AMP-110AMP-110 / ACTH receptor pathway / synthetic human corticotropin analog peptideMultiple indicationsdevelopmentUnited StatesCanada 8assets PaltusotineCRN00808 / PALSONIFY / SST2 / oral nonpeptide SST2 agonist / Endocrinology
Join 100,000+ practitioners on Fullscript with a free account today
Check the area for redness, itchiness or skin irritation
G.KoonenD
